Daphne Koller

12 statements across 2 episodes · 3 bullish · 3 bearish · 1 people on the record · first statement Jan 2, 2019 by Daphne Koller · said 3 times in 3 episodes since 2024 · across every show →

On the record as a speaker too: Daphne Koller's record, appearances and statements → this page counts the times other people say the name.

Mentions by year

brought up most by Martin Casado (1), Kim Branson (1), Balaji Srinivasan (1)

tap a year for its mentions
00112220242025episodesmentions
01220242025episodes it came up in
000.511220242025episodesmentions per episode
2025 1 mention in 1 episode
2024 2 mentions in 2 episodes 1 per episode

every mention, scene by scene, with the transcript →

Everything said about Daphne Koller, oldest first

Jan 2, 2019 negative
Assertion Partly supported
Koller: Theranos never published peer-reviewed papers or disclosed raw data
“We all know Theranos, you know, that's an extreme example, but, ah, the fact that they never had a peer-reviewed publication, they never presented their data in any way, they kept even potential customers from looking at the raw data, I mean, those are all rea…”
Daphne Koller Jan 2, 2019 ▶ 23:58 a16z Podcast | Breaking Into Bio
Jan 2, 2019
Assertion Not checkable as stated
Koller: In 2011, a big biology dataset was a couple hundred samples
“When I started Coursera back in 2011, 2012, a big data set was a couple hundred samples. That was really big, ok?”
Daphne Koller Jan 2, 2019 ▶ 18:26 a16z Podcast | Breaking Into Bio
Jan 2, 2019 negative
Insight
Koller: AUC-ROC curves rarely measure real-world performance
“The area under the ROC curve is rarely the thing that you actually care about. That was devised for radars back in the fifties, ok?”
Daphne Koller Jan 2, 2019 ▶ 26:38 a16z Podcast | Breaking Into Bio
Jan 2, 2019 bearish
Prediction Not checkable as stated
Koller: General artificial intelligence is not right around the corner
“I think one of the big risks that we run as a machine learning community is the incredible amount of hyperbole that's going on right now, where it's like, we're gonna have general intelligence right around the corner. We're not. Ok, we really aren't.”
Daphne Koller Jan 2, 2019 ▶ 21:41 a16z Podcast | Breaking Into Bio
Jan 2, 2019
Insight
Koller: Interdisciplinary innovators must risk looking foolish to ask basic questions
“If you're working at the boundary between two disciplines, you need to go in with the confidence that you are an expert in your domain, and it's okay for you to appear like a complete idiot in the other one, because if you're not going to ask those questions, …”
Daphne Koller Jan 2, 2019 ▶ 30:10 a16z Podcast | Breaking Into Bio
Jan 2, 2019 neutral
Insight
Koller: Healthcare tech adoption depends on workflow integration, not ML complexity
“It's not really about the machine learning inside the box. It's about how do you get it so that the physician doesn't even have to think about how to use your system. It just happens naturally.”
Daphne Koller Jan 2, 2019 ▶ 3:09 a16z Podcast | Breaking Into Bio
Jan 2, 2019
Insight
Koller: Tech founders in healthcare need domain co-founders or industry experience
“You really need to either spend serious time in either a hospital or a company, an existing company that actually has that as a market, or you get a co-founder who's had that.”
Daphne Koller Jan 2, 2019 ▶ 5:57 a16z Podcast | Breaking Into Bio
Sep 25, 2023 bullish
Prediction Not checkable as stated
Koller: AI's next impact frontier is interacting with the physical world
“The next frontier of what a, of the impact that AI can have is when AI starts to touch the physical world.”
Daphne Koller Sep 25, 2023 ▶ 16:51 Digital Biology with insitro's Daphne Koller
Sep 25, 2023 neutral
Assertion Not checkable as stated
Koller: Human technician variance is a primary signal in biological ML
“When you do biological experiments, one of the strongest signals when you apply machine learning to it is what was the technician who actually did the experiments? You could read that very clearly off the cells because they behave a little bit differently.”
Daphne Koller Sep 25, 2023 ▶ 16:23 Digital Biology with insitro's Daphne Koller
Sep 25, 2023 positive
Assertion Not checkable as stated
Koller: Biological datasets became large enough for meaningful ML around 2016
“What brought me back to this field back in 2016 post Coursera was the realization that we can now finally, for the first time, measure biology at scale, both at the cellular level, sometimes at subcellular level, and at the organism level via ways of quantitat…”
Daphne Koller Sep 25, 2023 ▶ 1:37 Digital Biology with insitro's Daphne Koller
Sep 25, 2023 neutral
Insight
Koller: ML lagged in life sciences due to lack of cross-disciplinary talent
“It wasn't having much of an impact in the life sciences, and I believe one of the main reasons for that is because there's so very few people who actually have the language of both disciplines and are able to bring them together.”
Daphne Koller Sep 25, 2023 ▶ 3:05 Digital Biology with insitro's Daphne Koller
Sep 25, 2023 bullish
Prediction Open · timeframe Dec 2030
Koller: Insitro will deliver AI-discovered medicines to patients by 2030
“The hope is that by the end of the Of this decade, we will have built this process, we will have run through it a number of times, we will have delivered some medicines to patients in our first tranche of indications, but then we will have learned enough from …”
Daphne Koller Sep 25, 2023 ▶ 10:53 Digital Biology with insitro's Daphne Koller
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.